title: Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis.
authors.affiliation: University of Vienna, Berlin. smj@2me.khl.magwien.gv.at
authors.forename: J S
authors.initials: JS
authors.lastname: Smolen
authors.forename: F C
authors.initials: FC
authors.lastname: Breedveld
authors.forename: G R
authors.initials: GR
authors.lastname: Burmester
authors.forename: B
authors.initials: B
authors.lastname: Combe
authors.forename: P
authors.initials: P
authors.lastname: Emery
authors.forename: J R
authors.initials: JR
authors.lastname: Kalden
authors.forename: L
authors.initials: L
authors.lastname: Klareskog
authors.forename: R N
authors.initials: RN
authors.lastname: Maini
authors.forename: R
authors.initials: R
authors.lastname: Numo
authors.forename: L B
authors.initials: LB
authors.lastname: van De Putte
authors.forename: P L
authors.initials: PL
authors.lastname: van Riel
authors.forename: V
authors.initials: V
authors.lastname: Rodriguez-Valverde
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D006801:Humans; D010147:Pain Measurement; D018579:Patient Selection; D010808:Physical Examination; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha